Hajras · هجرس

Hajras

Equity Research Report

Nahdi Medical

4164 · TASI — Main Market · 2026-07-29

Snapshot

Price96.50 SAR

Market cap12.54B SAR

P/E15.10×

P/B4.57×

ROE30.28%

Dividend yield5.80%

Revenue CAGR5.83%

Valuation (Hajras)

Fair value77.74 SAR

Ratingovervalued

Upside/(downside)-19.44%

DCF98.95

DDM84.48

Graham55.40

Discount rate9.83%

DCF growth8.00%

Financials

SAR	FY22	FY23	FY24	FY25
Revenue	8.62B	8.71B	9.45B	10.21B
Net income	887.81M	892.62M	820.72M	830.74M
EPS	6.83	6.87	6.31	6.39
DPS	2.31	5.50	5.50	5.60
Equity	2.24B	2.46B	2.59B	2.74B

This report is for informational purposes only and is not investment advice. Sources: Hajras valuation & financials, Yahoo/SEC EDGAR, and investment-house targets.